Thundon Ngamprasertchai

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

William HK Schilling, Podjanee Jittamala, James A Watson et al. · The Lancet Infectious Diseases · 2023 · 85 citations · Full text

Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency

Visanu Thamlikitkul, Yanina Dubrovskaya, Pooja Manchandani et al. · Antimicrobial Agents and Chemotherapy · 2016 · 66 citations · Full text

Adjuvant chemotherapy in resectable cholangiocarcinoma patients

Kosin Wirasorn, Thundon Ngamprasertchai, Narong Khuntikeo et al. · Journal of Gastroenterology and Hepatology · 2013 · 44 citations

Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand

Thundon Ngamprasertchai, Adhiratha Boonyasiri, Lantharita Charoenpong et al. · Infection and Drug Resistance · 2018 · 28 citations · Full text

Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)

Podjanee Jittamala, William HK Schilling, James A Watson et al. · The Journal of Infectious Diseases · 2023 · 25 citations · Full text